Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORANGE trial of early discharge versus standard inpatient care for low-risk febrile neutropenia
ISRCTN18467252Phase 3Terminated
- Sponsor
- University of Birmingham
- Start
- Jul 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of ciprofloxacin and amoxicillin + clavulanate in febrile neutropenia (FN) and neutropenic sepsis (FN) (2 arms), sponsored by University of Birmingham. Primary endpoints: Total number of days of hospitalisation and Incidence of serious adverse events. Started Jul 2006; status: terminated.
02
Drugs
ciprofloxacinamoxicillin + clavulanate
03
Conditions
febrile neutropenia (FN)neutropenic sepsis (FN)
Beyond the preview
Go deeper on ISRCTN18467252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18467252.